Analysts Offer Insights on Healthcare Companies: Actinium Pharmaceuticals (ATNM), BioMarin Pharmaceutical (BMRN) and BioCryst (BCRX)
at www.tipranks.com (Wed, 21-Oct 9:01 AM)
Pantginis Reiterates Buy on ATNM-400 Following HER3 Target Disclosure and Early Phase 1 Data; $4 Price Target Maintained
at www.tipranks.com (Tue, 20-Oct 6:26 AM)
